In this section
As well as affecting personal wellbeing, relationships and family life, sexually transmitted infections are a major cause of serious health problems, including pelvic inflammatory disease, ectopic pregnancy, infertility and cervical cancer.
Incidence of sexually transmitted infections is high and has been increasing in England for the past 20 years (1).
Almost half a million people in the UK have a sexually transmitted disease and one in ten young people diagnosed with a sexually transmitted infections become re-infected within a year (1).
Rates are also increasing among older groups – where the incidence rate has more than doubled to 13,000 (for those aged 45 and over between 2000 and 2009) (2). Traditionally public health campaigns are not aimed at older age groups (2,3).
HIV and AIDS
The number of people living with HIV has more than doubled in the past 10 years, but the number of cases of AIDS has remained stable.
HIV (human immunodeficiency virus) is a virus that infects and gradually destroys the cells of the body's immune system. When the number of these cells drops so low that the immune system is weakened, the patient is vulnerable to multiple diseases, such as cancer and pneumonia, a condition that is called late-stage HIV or AIDS (acquired immune deficiency syndrome) (5,6).
More than 6,000 new cases of HIV are diagnosed every year in the UK, and despite sexual health promotion, a recent decline appears to be levelling out (6). Just over half of people diagnosed in the UK acquired the infection here (1).
HIV and AIDS diagnoses and people living with diagnosed HIV in the United Kingdom, 2001-2010
Source: Health Protection Agency (2011). Report. HIV in the United Kingdom
However, the number of people dying due to late-stage HIV or AIDS has not risen since 1998, mainly because of the effectiveness of HIV drugs. There is a rising number of people living with HIV – more than double the number 10 years ago (6) – who have an ongoing need for health and social care.
New, re-emerging and drug resistant diseases
New or re-emerging infectious diseases are unpredictable in their timing and impact.
The impact of new and re-emerging infectious diseases in the future is uncertain.
SARS emerged in Guangdong province in China in 2002 and rapidly spread to many other countries, including the UK, causing more than 700 deaths worldwide (8). But new strains of flu will not neccessarily transmit to humans: bird flu first emerged as a threat in 1997 and again in 2003, but has not yet caused a pandemic, while swine flu caused an immediate pandemic in 2009 (9,10).
There are also threats from re-emerging communicable diseases, such as tuberculosis (TB), which were previously thought to be controlled in the UK (11). The highest rates of TB are in London, with major problems in certain boroughs: homeless people, prisoners and problem drug users are at particular risk (12). Rates are also 21 times higher in those born outside the UK than those born in the UK, with most people affected by TB coming from South Asia and sub-Saharan Africa (11). Although migration is high in London, other urban areas have significant problems with TB – for example, 11 per cent of cases in 2010 were in the West Midlands (11).
Drug resistant disease
Antibiotics kill or interfere with the growth of micro-organisms, especially bacteria. Since the introduction of penicillin in the 1940s, antimicrobial medicines have been used to treat many infectious diseases including pneumonia and TB.
Antimicrobial medicines also help reduce the risk of complications after surgery and chemotherapy and support the care of premature babies.
In recent years microbes have emerged that are resistant to antimicrobial medicines, making these treatments ineffective and enabling infection to spread. Some bacteria are naturally resistant; new resistances also arise spontaneously and then multiply. An estimated 25,000 patients die in the EU each year from multi-drug resistant bacteria (13).
The more antibiotics are used, the greater the risk of resistant strains developing. The resistant bacteria then spread through direct contact. Resistance is a particular problem in hospitals and places like care homes for older people, where vulnerable people are gathered together. Patients in hospital also often need antibiotics, and intensive use means resistant bacteria are more likely to emerge. The problem is compounded by failure to develop new antibiotics that can deal with the new resistant strains.
The European Union and the World Health Organisation have both identified antimicrobial resistance as a priority. The current focus is on improving surveillance, reducing unnecessary prescribing of antibiotics and supporting the search for new antibiotics (13).
- Health Protection Agency (2011). Report. Annual Report and Accounts 2010/11. London: The Stationery Office
- Family Planning Association (2010). Report. ‘FPA warns of rising STIs and poor sexual health in the over 50s’
- Bodley-Tickell AT, Olowokure B, Bhaduri S, White DJ, Ward D, Ross JDC, Smith G, Duggal HV, Goold P on behalf of West Midlands STI Surveillance Project (2008). Report. ‘Trends in sexually transmitted infections (other than HIV) in older people: analysis of data from an enhanced surveillance system’. Sexually Transmitted Infections, vol 84, pp 312-7
- World Health Organization (2011). Factsheet. Emergence of Multi-Drug Resistant Neisseria Gonorrhoeae - Threat of Global Rise in Untreatable Sexually Transmitted Infections
- Terrence Higgins Trust (2012). Report. ‘What are HIV and AIDS?’. Terrence Higgins Trust website
- Health Protection Agency (2011). Report. HIV in the United Kingdom: 2011 report. London: Health Protection Services, Colindale.
- Ruf M, Korkodilos M, Harris J, Foreman C (2011). Report. London Adult HIV Health Needs Assessment: Executive Summary. London: NHS London
- World Health Organization (2004). Report. ‘Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003.’
- Department of Health (2011). Report. UK Influenza Pandemic Preparedness Strategy 2011
- Health Protection Agency (2012). Report. Pandemic influenza
- Health Protection Agency (2011). Report. Tuberculosis in the UK: 2011 report
- National Institute for Health and Clinical Excellence (2012). Identifying and managing tuberculosis among hard-to-reach groups. NICE public health guidance 37
- ECDC/EMEA (2009). Report. The bacterial challenge: time to react